Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 61,100 KRW
Change Today +1,100 / 1.83%
Volume 15.9K
003850 On Other Exchanges
Korea SE
As of 2:22 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

boryung pharmaceutical co (003850) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/3/15 - 81,800
52 Week Low
09/15/14 - 35,135
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BORYUNG PHARMACEUTICAL CO (003850)

Related News

No related news articles were found.

boryung pharmaceutical co (003850) Related Businessweek News

No Related Businessweek News Found

boryung pharmaceutical co (003850) Details

Boryung Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers various active pharmaceutical ingredients, including doxorubicin hydrochloride, tamsulosin hydrochloride, epirubicin hydrochloride, glimepiride, captopril, alibendole, alacepril, torsemide, nitrendipine, fluconazole, and ondansetron hydrochloride. It also manufactures and licenses various finished products in the areas of antibiotics, dermatology, cardiovascular, antineoplastics and antiemetics, urology, gastrointestinal, amino acids injections, dialysis, antidiabetes, CNS, vaccines, respiratory, anti-histamines, and ophthalmics, as well as antipyretic, analgesics, anti-inflammatory, and other areas. The company was formerly known as Boryung Drugs Co., Ltd. and changed its name to Boryung Pharmaceutical Co., Ltd. in February 1966. Boryung Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Seoul, South Korea.

Founded in 1963

boryung pharmaceutical co (003850) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

boryung pharmaceutical co (003850) Key Developments

Zuellig Pharma and Boryung Sign Licensing Agreement for Hypertension Drug Kanarb in Southeast Asia

Boryung Pharmaceutical (South Korea) has signed a licensing agreement with Zuellig Pharma (Hong Kong) for Boryung's hypertension drug Kanarb (fimasartan) in 13 Southeast Asian countries, the companies said in a statement. Under the agreement, Zuellig Pharma will launch and market Kanarb with particular focus on Indonesia, Malaysia, Philippines, Singapore, Thailand, and Vietnam. The companies also aim to sign a licensing agreement for Kanarb combination drugs, including diuretics and rosuvastatin.

Boryung Pharmaceutical Co., Ltd., Annual General Meeting, Mar 27, 2015

Boryung Pharmaceutical Co., Ltd., Annual General Meeting, Mar 27, 2015., at 10:00 Korea Standard Time. Location: 136 Boryeong Building in Jongno Changgyeonggung 17th floor auditorium. Agenda: To approve financial statements; to appoint directors; to approve remuneration limit; and to approve audit remuneration.

JW Holdings, Chong Kun Dang, Boryung Pharm, and BC World Pharm Sign KRW 200 Billion Agreement with Sudair Pharmaceutical to Export Products to Saudi Arabia Over the Next Five Years

JW Holdings, Chong Kun Dang, Boryung Pharm, and BC World Pharm have signed agreements totaling approximately KRW 200 billion with Sudair Pharmaceutical to export products to Saudi Arabia over the next five years.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003850:KS 61,100.00 KRW +1,100

003850 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,248 GBp +130.50
View Industry Companies

Industry Analysis


Industry Average

Valuation 003850 Industry Range
Price/Earnings 19.1x
Price/Sales 1.2x
Price/Book 2.4x
Price/Cash Flow 18.0x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BORYUNG PHARMACEUTICAL CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at